Skip to Main Content

Paper Details

Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial.
J Thorac Cardiovasc Surg
2
2023
Author NameAffiliation
Nasser K AltorkiNewYork-Presbyterian Hospital
  • 1 - 1

Datasets

Release 1.2